Mexican Pharmaceutical Company Casa Saba Refinances MXN7.72 Billion Loan
11 Agosto 2011 - 6:07PM
Noticias Dow Jones
Mexican pharmaceuticals distributor Grupo Casa Saba SAB (SAB,
SAB.MX) said Thursday it has refinanced a 7.72-billion-peso ($628
million) bridge loan, extending it out to seven years.
The company took out the loan last August from HSBC's Mexican
unit and local banking group Grupo Financiero Banorte SAB (GBOOY,
GFNORTE.MX) so that it could complete its $498 million purchase of
a majority stake in Chilean drug-store operator Farmacias Ahumada
SA (FASA.SN).
The company said the loan is now divided into two parts, one
with a shorter-term duration at the 28-day TIIE interbank rate plus
2.25% and the other with a longer-term duration at TIIE plus 2.76%.
The TIIE was 4.81% Thursday.
Casa Saba said the refinanced bridge loan improves its debt
profile.
The company had net sales in 2010 of MXN34.2 billion.
By Amy Guthrie, Dow Jones Newswires; (5255) 5980-5177,
amy.guthrie@dowjones.com
Saratoga Investment (NYSE:SAB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Saratoga Investment (NYSE:SAB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Saratoga Investment Corp (New York Stock Exchange): 0 recent articles
Más de Grupo Casa Saba S.A.B. de C.V. ADS Artículos de Noticias